PMA device
Protege Gps & Protege Rx Carotid Stent Systems
Medtronic Vascular, Inc. · Stent, Carotid (NIM, Class III) · First FDA decision Oct 8, 2008, newest Mar 8, 2011Carotid artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
2
Naming "Protege Gps Protege"
MAUDE reports
0
Brand "Protege Gps Protege", since 2015
PubMed studies
0
Mentioning "Protege Gps Protege"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Protege Gps & Protege Rx Carotid Stent Systems
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- PROTEGE GPS & PROTEGE RX CAROTID STENT SYSTEMSPMA supplement
P060001-S011 · Decided Mar 8, 2011 · 20 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, carotid (NIM) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R8Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R7Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R6Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R3Updated Sep 21, 2026
- Carotid Artery Stenting in Post-Approval StudiesNational analysisReview closedCAG-00259NUpdated Sep 17, 2026
- Carotid Artery StentingNational analysisReview closedCAG-00085RUpdated Sep 17, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Protege Gps Protege", any status and sponsor, newest update first.
- DURABILITY™ Iliac StudyCompleted
Medtronic EndovascularPublic (MDT)
NCT01400919 · 75 participants · Start Jul 2011 · Primary completion Nov 2013
Device: Protégé® EverFlex™ Self-Expanding Stent System, and Protégé® GPS™ Self-Expanding Stent System. · For: Peripheral Arterial Disease; Claudication
Sites: New York, New York
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Protege Gps Protege", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NIM
2,799 reports: 1,699 malfunction, 994 injury, 98 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0878-2015 · Started Dec 4, 2014 · Posted by FDA Dec 29, 2014
Reason given: Two production lots of the Protege Rx Tapered Carotid Stent Systems (SECX-10-7-40-135, Lot # 9922452 & SEPX-8-6-40-135, Lot # 9922795) because of a product labeling error.
Cause as FDA categorized it: Packaging process control · Device type: Stent, Carotid (NIM)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Protege Gps Protege"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NIM.
- XACT® Carotid Stent SystemAbbott Vascular, Inc. · PMA 2025
- ENROUTE Transcarotid Stent SystemBoston Scientific Corporation · PMA 2023
- Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2016
- Carotid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2024
- Acculink Carotid Stent System and Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2017
- Roadsaver/CASPER Carotid Stent DeviceMicroVention, Inc. · PMA 2025
- Cartoid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2012
- Cordis Precise Nitinol StentCordis US Corporation · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.